News
First major insurer covers Eisai’s Alzheimer’s drug Leqembi
In a big boost to Eisai and partner Biogen, the US Department of Veterans Affairs has agreed to cover their new amyloid-busting Alzheimer’s disease therapy Leqembi, becomi
